Published in J Virol on January 01, 1971
Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A (2001) 5.46
Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc Natl Acad Sci U S A (1993) 4.11
The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J Virol (1972) 4.04
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Dissociation of vesicular stomatitis virus and relation of the virion proteins to the viral transcriptase. J Virol (1972) 3.84
Mass and molecular composition of vesicular stomatitis virus: a scanning transmission electron microscopy analysis. J Virol (1985) 3.79
Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation. J Virol (1977) 2.77
Carbohydrate composition of vesicular stomatitis virus. J Virol (1971) 2.40
Protein kinase and phosphoproteins of vesicular stomatitis virus. J Virol (1974) 2.11
Localization of membrane-associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents. J Virol (1980) 1.89
Association of vesicular stomatitis virus glycoprotein with virion membrane: characterization of the lipophilic tail fragment. J Virol (1975) 1.88
Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J Virol (2002) 1.81
Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components. J Virol (1975) 1.77
Entry of vesicular stomatitis virus into L cells. J Virol (1971) 1.65
Spin-labeled electron spin resonance study of the lipid-containing membrane of influenza virus. Proc Natl Acad Sci U S A (1971) 1.57
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity. J Virol (1982) 1.54
Lipids and membrane microdomains in HIV-1 replication. Virus Res (2009) 1.51
Localization of the membrane-associated region of vesicular stomatitis virus M protein at the N terminus, using the hydrophobic, photoreactive probe 125I-TID. J Virol (1990) 1.46
Interactions of vesicular stomatitis virus with murine cell surface antigens. J Virol (1976) 1.35
Mutants of Sindbis virus. III. Host polypeptides present in purified HR and ts103 virus particles. J Virol (1978) 1.34
Accumulation of chlamydial lipopolysaccharide antigen in the plasma membranes of infected cells. Infect Immun (1989) 1.30
Inhibition of viral transcriptase by immunoglobulin directed against the nucleocapsid NS protein of vesicular stomatitis virus. J Virol (1975) 1.27
The lipidomes of vesicular stomatitis virus, semliki forest virus, and the host plasma membrane analyzed by quantitative shotgun mass spectrometry. J Virol (2009) 1.25
Intracellular appearance of a glycoprotein in VSV-infected BHK cells lacking the membrane-anchoring oligopeptide of the viral G-protein. EMBO J (1984) 1.23
Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid. J Virol (1975) 1.19
Molecular weights of vesicular stomatitis virus and its defective particles by laser light-scattering spectroscopy. J Virol (1973) 1.16
Use of antiviral-antiferritin hybrid antibody for localization of viral antigen in plasma membrane. J Virol (1971) 1.15
Activation of mouse lymphocytes by vesicular stomatitis virus. J Virol (1980) 1.04
The soluble glycoprotein of vesicular stomatitis virus is formed during or shortly after the translation process. J Virol (1986) 1.01
Interaction of vesicular stomatitis virus with lipid vesicles: depletion of cholesterol and effect on virion membrane fluidity and infectivity. J Virol (1978) 1.00
Temperature-dependent host range mutation in vesicular stomatitis virus affecting polypeptide L. J Virol (1977) 0.91
Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach. Virol J (2009) 0.86
Fatty chains of different lipid classes of Semliki forest virus and host cell membranes. J Virol (1972) 0.85
Inhibition of a vesicular stomatitis virus mutant by rifampin. J Virol (1974) 0.85
Incorporation of L cell sterols into vesicular stomatitis virus. J Virol (1972) 0.83
Comparison of the lipids of intracellular and extracellular rabies viruses. J Virol (1973) 0.81
Disulfide-bonded discontinuous epitopes on the glycoprotein of vesicular stomatitis virus (New Jersey serotype). J Virol (1992) 0.80
Rifampin-susceptible mutant of vesicular stomatitis virus: protein and RNA synthesis. J Virol (1977) 0.79
Thermal inactivation of Newcastle disease virus. I. Coupled inactivation rates of hemagglutinating and neuraminidase activities. J Virol (1973) 0.77
Lipids of rabies virus and BHK-21 cell membranes. J Virol (1977) 0.77
Computational virology: From the inside out. Biochim Biophys Acta (2016) 0.76
Recovery of protective activity in rabies virus vaccines concentrated and purified by four different methods. Appl Microbiol (1972) 0.75
Phospholipid composition of Venezuelan equine encephalitis virus. J Virol (1971) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Phosphorus assay in column chromatography. J Biol Chem (1959) 60.56
The thiobarbituric acid assay of sialic acids. J Biol Chem (1959) 43.78
PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL. J Lipid Res (1964) 15.95
A new method for the direct determination of serum cholesterol. J Lab Clin Med (1953) 11.05
Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus. J Mol Biol (1966) 6.61
BIOLOGIC PROPERTIES OF TWO PLAQUE VARIANTS OF VESICULAR STOMATITIS VIRUS (INDIANA SEROTYPE). J Immunol (1963) 5.30
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Structural proteins of vesicular stomatitis viruses. J Virol (1969) 4.70
Comparison of membrane protein glycopeptides of Sindbis virus and vesicular stomatitis virus. J Virol (1970) 4.54
Identification of the membrane protein and "core" protein of Sindbis virus. Proc Natl Acad Sci U S A (1968) 4.52
The fine structure of vesicular stomatitis virus. Virology (1968) 4.31
PURIFICATION AND PARTIAL CHEMICAL ANALYSIS OF SINDBIS VIRUS. Virology (1963) 3.96
The proteins of biologically active sub-units of vesicular stomatitis virus. J Gen Virol (1970) 3.44
Complete separation of lipid classes on a single thin-layer plate. J Lipid Res (1966) 3.29
Concentration and purification of vesicular stomatitis virus by polyethylene glycol "precipitation". Virology (1970) 3.20
Proteins of vesicular stomatitis virus. II. Immunological comparisons of viral antigens. J Virol (1970) 2.90
Biophysical studies of vesicular stomatitis virus. J Bacteriol (1966) 2.86
Simple charring method for determination of lipids. J Lipid Res (1966) 2.75
Phagocytosis of latex beads by Acahamoeba castellanii (Neff). 3. Isolation of the phagocytic vesicles and their membranes. J Cell Biol (1969) 2.59
The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus. J Gen Virol (1967) 2.57
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Carbohydrate content of the membrane protein of Sindbis virus. J Mol Biol (1970) 2.45
Cellular membranes: the isolation and characterization of the plasma and smooth membranes of HeLa cells. Arch Biochem Biophys (1968) 2.30
Analytical separation of nonlipid water soluble substances and gangliosides from other lipids by dextran gel column chromatography. J Am Oil Chem Soc (1965) 2.22
Characterization and quantification of red cell lipids in normal man. J Lipid Res (1964) 2.03
Lipid composition of mitochondria from bovine heart, liver, and kidney. J Lipid Res (1967) 1.50
Membranes of animal cells. IV. Lipids of the L cell and its surface membrane. J Biol Chem (1969) 1.47
Plasma membrane lipids and parainfluenza virus assembly. Virology (1970) 1.44
Vesicular stomatitis virus maturation sites in six different host cells. J Gen Virol (1970) 1.41
The lipids of paramyxoviruses: a comparative study of Sendai and Newcastle disease viruses. Virology (1968) 1.26
Evidence for a host cell component in vesicular stomatitis virus. J Gen Virol (1968) 1.23
Studies on the hemolysis of red blood cells by mumps virus. IV. Quantitative study of changes in red blood cell lipides and of virus lipides. J Exp Med (1959) 1.12
Enumeration of VSV particles and a demonstration of their growth kinetics by electron microscopy. Proc Soc Exp Biol Med (1967) 1.11
Fatty acid composition of three strains of Newcastle disease virus. Virology (1969) 1.05
Nature and function of the structural phospholipids of an arbovirus. J Mol Biol (1969) 0.99
Determination of hexosamines. Arch Biochem Biophys (1961) 0.92
The lipid constituents of influenza virus, chick allantoic membrane and sedimentable allantoic protein. Virology (1958) 0.91
Myxovirus envelope proteins: a directing influence on the fatty acids of membrane lipids. Science (1969) 0.86
Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus. J Mol Biol (1966) 6.61
Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties. Virology (1966) 6.37
Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions. J Virol (1972) 5.93
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Structural proteins of vesicular stomatitis viruses. J Virol (1969) 4.70
Protein composition of the structural components of vesicular stomatitis virus. J Virol (1969) 4.54
The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J Virol (1972) 4.04
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology (1979) 3.80
Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J Virol (1979) 3.54
Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference. Virology (1966) 3.49
L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus. J Virol (1973) 3.26
Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation. J Virol (1977) 2.77
Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46
Carbohydrate composition of vesicular stomatitis virus. J Virol (1971) 2.40
Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci U S A (1965) 2.37
Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus. J Virol (1972) 2.37
Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1995) 2.23
Protein kinase and phosphoproteins of vesicular stomatitis virus. J Virol (1974) 2.11
Effect of arildone on modifications of poliovirus in vitro. Virology (1980) 2.10
Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins. J Virol (1971) 2.05
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol (1987) 1.98
Localization of membrane-associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents. J Virol (1980) 1.89
Association of vesicular stomatitis virus glycoprotein with virion membrane: characterization of the lipophilic tail fragment. J Virol (1975) 1.88
Ribonucleic acid species of intracellular nucleocapsids and released virions of vesicular stomatitis virus. J Virol (1972) 1.86
Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies. J Virol (1986) 1.78
Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components. J Virol (1975) 1.77
Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J Virol (1989) 1.73
Role of matrix protein in assembling the membrane of vesicular stomatitis virus: reconstitution of matrix protein with negatively charged phospholipid vesicles. Biochemistry (1981) 1.71
Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology (1966) 1.67
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants. J Virol (1985) 1.66
Sialoglycoprotein of vesicular stomatitis virus: role of the neuraminic acid in infection. J Virol (1974) 1.63
Action of interferon: kinetics and differential effects on viral functions. J Virol (1970) 1.63
The plus-strand leader RNA of VSV inhibits DNA-dependent transcription of adenovirus and SV40 genes in a soluble whole-cell extract. Cell (1982) 1.61
Glycoprotein biosynthesis. Incorporation of glycosyl groups into endogenous acceptors in a Golgi apparatus-rich fraction of liver. J Biol Chem (1971) 1.60
Location of the transcription defect in group I temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1974) 1.58
Mosquito cells infected with vesicular stomatitis virus yield unsialylated virions of low infectivity. J Virol (1975) 1.57
Differential inhibition of host protein synthesis in L cells infected with RNA - temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1976) 1.55
Enveloped viruses as model membrane systems: microviscosity of vesicular stomatitis virus and host cell membranes. Biochemistry (1976) 1.54
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity. J Virol (1982) 1.54
Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus. J Virol (1978) 1.51
Reconstitution into liposomes of the glycoprotein of vesicular stomatitis virus by detergent dialysis. J Biol Chem (1979) 1.48
Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J Virol (1995) 1.46
Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule. Infect Immun (1984) 1.45
Reversible inhibition of interferon synthesis by puromycin: evidence for an interferon-specific messenger RNA. Proc Natl Acad Sci U S A (1965) 1.44
RNA- temperature-sensitive mutants of vesicular stomatitis virus: L-protein thermosensitivity accounts for transcriptase restriction of group I mutants. J Virol (1976) 1.44
Use of UV irradiation to identify the genetic information of vesicular stomatitis virus responsible for shutting off cellular RNA synthesis. J Virol (1979) 1.44
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus. J Virol (1994) 1.39
Structural proteins of two salmonid rhabdoviruses. J Virol (1975) 1.36
Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors. J Virol (1988) 1.33
Classification of the New Jersey serotype of vesicular stomatitis virus into two subtypes. J Virol (1978) 1.32
Enzymatic transfer of 14C-glucosamine from UDP-N-acetyl-14C-glucosamine to endogenous acceptors in a Golgi apparatus-rich fraction from liver. Biochem Biophys Res Commun (1969) 1.32
Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product. J Virol (1985) 1.28
Inhibition of viral transcriptase by immunoglobulin directed against the nucleocapsid NS protein of vesicular stomatitis virus. J Virol (1975) 1.27
Influence of the peripheral matrix protein of vesicular stomatitis virus on the membrane dynamics of mixed phospholipid vesicles: fluorescence studies. Biochemistry (1983) 1.23
Inhibition of transcription by immunoglobulins directed against the ribonucleoprotein of homotypic and heterotypic vesicular stomatitis viruses. J Virol (1978) 1.22
Inhibition by aurintricarboxylic acid and polyethylene sulfonate of RNA transcription of vesicular stomatitis virus. J Virol (1975) 1.21
Microviscosity of togavirus membranes studied by fluorescence depolarization: influence of envelope proteins and the host cell. J Virol (1976) 1.21
Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis. J Virol (1979) 1.20
Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid. J Virol (1975) 1.19
Activation of the alternative complement pathway by enveloped viruses containing limited amounts of sialic acid. Virology (1981) 1.17
Rabbit macrophage interferons. II. Some physicochemical properties and estimations of molecular weights. J Exp Med (1967) 1.16
Use of antiviral-antiferritin hybrid antibody for localization of viral antigen in plasma membrane. J Virol (1971) 1.15
Antigenicity, function, and conformation of synthetic oligopeptides corresponding to amino-terminal sequences of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1988) 1.14
Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA. J Virol (1983) 1.13
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes. Virology (1987) 1.12
Rapid detection of cytomegalovirus by fluorescent monoclonal antibody staining and in situ DNA hybridization in a dram vial cell culture system. J Clin Microbiol (1988) 1.12
Isolation and characterization of the nonglycosylated membrane protein and a nucleocapsid complex from the paramyxovirus SV5. Virology (1975) 1.11
Viral membranes: model systems for studying biological membranes. CRC Crit Rev Biochem (1979) 1.10
Lipid organization of the membrane of vesicular stomatitis virus. J Biol Chem (1978) 1.10
Nucleotide sequence and secondary structure of VSV leader RNA and homologous DNA involved in inhibition of DNA-dependent transcription. Cell (1984) 1.10
Reversal by certain polyanions of an endogenous inhibitor of the vesicular stomatitis virus-associated transcriptase. J Biol Chem (1978) 1.09
Effect of phospholipase C and cholesterol oxidase on membrane integrity, microviscosity, and infectivity of vesicular stomatitis virus. Biochemistry (1977) 1.08
The incorporation of 14C-glucosamine from UDP-N-acetyl-14C-glucosamine into liver microsomal protein in vitro. Arch Biochem Biophys (1969) 1.07
Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses. Intervirology (1979) 1.07
Glycoprotein micelles isolated from vesicular stomatitis virus spontaneously partition into sonicated phosphatidylcholine vesicles. Virology (1980) 1.07
Adenosine-5'-O-(3-thiotriphosphate) as an affinity probe for studying leader RNA's transcribed by vesicular stomatitis virus. J Biol Chem (1979) 1.05
Inhibition of cellular DNA synthesis by vesicular stomatitis virus. J Virol (1981) 1.04
Transcription inhibition site on the M protein of vesicular stomatitis virus located by marker rescue of mutant tsO23(III) with M-gene expression vectors. J Virol (1989) 1.04
Envelope proteins of vesicular stomatitis virions: accessibility to iodination. Virology (1974) 1.04
Activation of mouse lymphocytes by vesicular stomatitis virus. J Virol (1980) 1.04
Site-specific mutations in vectors that express antigenic and temperature-sensitive phenotypes of the M gene of vesicular stomatitis virus. J Virol (1988) 1.03
Biological properties of the VSV glycoprotein. 1. Effects of the isolated glycoprotein on host macromolecular synthesis. Virology (1978) 1.03
Glycoprotein metabolism: a UDP-galactose-glycoprotein galactosyltransferase of rat serum. Biochem Biophys Res Commun (1971) 1.02
Pyrene phospholipid as a biological fluorescent probe for studying fusion of virus membrane with liposomes. Biochemistry (1988) 1.02
Spontaneous mutations leading to antigenic variations in the glycoproteins of vesicular stomatitis virus field isolates. Virology (1990) 1.01
Effect of the vesicular stomatitis virus matrix protein on the lateral organization of lipid bilayers containing phosphatidylglycerol: use of fluorescent phospholipid analogues. Biochemistry (1985) 1.01
Interaction of vesicular stomatitis virus with lipid vesicles: depletion of cholesterol and effect on virion membrane fluidity and infectivity. J Virol (1978) 1.00
Transient expression and sequence of the matrix (M1) gene of WSN influenza A virus in a vaccinia vector. Virology (1988) 0.99
Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector. Virology (1989) 0.97
Vesicular stomatitis virus infection reduces the number of active DNA-dependent RNA polymerases in myeloma cells. J Biol Chem (1979) 0.97
Virion RNA polymerases of two salmonid rhabdoviruses. J Virol (1977) 0.97
The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes. J Exp Med (1981) 0.97
Inhibition of DNA-dependent transcription by the leader RNA of vesicular stomatitis virus: role of specific nucleotide sequences and cell protein binding. Mol Cell Biol (1985) 0.97
Sendai virus glycoproteins are T cell-dependent B cell mitogens. Infect Immun (1983) 0.95
The structure of vesicular stomatitis virus membrane. A phosphorus nuclear magnetic resonance approach. Biochim Biophys Acta (1977) 0.94